Eye imaging breakthrough: new way to measure disease severity

NCT ID NCT07347119

First seen Jan 28, 2026 · Last updated Apr 29, 2026 · Updated 10 times

Summary

This study looks at 120 adults with central serous chorioretinopathy (CSC), an eye condition that causes fluid buildup and vision problems. Researchers will use a special type of eye scan called ultra-widefield OCTA to measure blood vessel patterns and fluid levels. The goal is to create a more precise way to track the disease, not to test a new treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CENTRAL SEROUS CHORIORETINOPATHY (CSC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Zhongshan Ophthalmic Center, Sun Yat-sen University

    Guangzhou, Guangdong, 510060, China

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.